Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Rush Enterprises Class A
RUSHA
$9.6B
| $8.53M | ﹤0.01% |
463,075
-37,098
| -7% | -$618K |
|
1927
IMAX
IMAX
$2.9B
| $8.52M | ﹤0.01% |
760,482
+19,690
| +3% | +$230K |
|
1928
Coca-Cola Femsa
KOF
$22.9B
| $8.5M | ﹤0.01% |
193,840
+20,988
| +12% | +$884K |
|
1929
Dine Brands
DIN
$447M
| $8.49M | ﹤0.01% |
201,728
-71,411
| -26% | -$2.88M |
|
1930
TG Therapeutics
TGTX
$7.46B
| $8.49M | ﹤0.01% |
435,818
+72,918
| +20% | +$1.17M |
|
1931
PC Connection
CNXN
$2.05B
| $8.49M | ﹤0.01% |
183,101
+1,781
| +1% | +$75.1K |
|
1932
Amphastar Pharmaceuticals
AMPH
$889M
| $8.48M | ﹤0.01% |
377,604
+4,624
| +1% | +$84.7K |
|
1933
Assured Guaranty
AGO
$3.38B
| $8.46M | ﹤0.01% |
346,755
-10,497
| -3% | -$286K |
|
1934
CTS Corp
CTS
$1.81B
| $8.45M | ﹤0.01% |
421,776
-9,600
| -2% | -$206K |
|
1935
Veeco
VECO
$3.2B
| $8.45M | ﹤0.01% |
626,630
-4,762
| -0.8% | -$54.7K |
|
1936
Vertiv
VRT
$113B
| $8.44M | ﹤0.01% |
+622,424
| New | +$7.25M |
|
1937
TechTarget
TTGT
$278M
| $8.43M | ﹤0.01% |
280,874
-10,731
| -4% | -$271K |
|
1938
Pan American Silver
PAAS
$20B
| $8.43M | ﹤0.01% |
277,288
+240,853
| +661% | +$5.71M |
|
|
HTLF
1939
DELISTED
Heartland Financial USA, Inc.
HTLF
| $8.4M | ﹤0.01% |
251,300
-5,649
| -2% | -$177K |
|
1940
Universal Electronics
UEIC
$67.9M
| $8.37M | ﹤0.01% |
178,759
+78
| +0% | +$3.28K |
|
1941
Marcus & Millichap
MMI
$1.2B
| $8.35M | ﹤0.01% |
289,422
-6,241
| -2% | -$176K |
|
1942
Nomad Foods
NOMD
$1.64B
| $8.33M | ﹤0.01% |
388,159
-32,811
| -8% | -$684K |
|
1943
ATN International
ATNI
$488M
| $8.32M | ﹤0.01% |
137,440
+913
| +0.7% | +$54.8K |
|
|
DMC
1944
Del Monte Corp
DMC
$1.43B
| $8.32M | ﹤0.01% |
337,748
-290,413
| -46% | -$7.61M |
|
1945
Scorpio Tankers
STNG
$3.98B
| $8.26M | ﹤0.01% |
644,749
-9,564
| -1% | -$173K |
|
1946
Photronics
PLAB
$1.96B
| $8.25M | ﹤0.01% |
741,164
-21,633
| -3% | -$248K |
|
1947
Vanguard Extended Market ETF
VXF
$32.3B
| $8.23M | ﹤0.01% |
69,576
+5,445
| +8% | +$584K |
|
1948
Adtran
ADTN
$684M
| $8.2M | ﹤0.01% |
750,484
-10,857
| -1% | -$112K |
|
1949
OFG Bancorp
OFG
$2.28B
| $8.18M | ﹤0.01% |
611,660
+5,633
| +0.9% | +$67.9K |
|
1950
Ambev
ABEV
$43.2B
| $8.15M | ﹤0.01% |
3,088,806
-123,588
| -4% | -$291K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.